MediciNova, Inc.
MNOVNASDAQHealthcare● Active
$1.30
$-0.01(-0.38%)
Market Cap$63741514
P/E Ratio—
52W High$1.96
52W Low$1.17
MediciNova, Inc. (MNOV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MNOV · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.41M | $0.00M | $1.00M | $0.00M | $4.04M |
| Cost of Revenue | $0.38M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.03M | $0.00M | $1.00M | $0.00M | $4.04M |
| Gross Margin %(computed) | 7.58% | — | 100.00% | — | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $7.15M | $7.20M | $5.66M | $9.14M | $8.10M |
| G&A Expenses | $6.16M | $5.22M | $4.98M | $5.24M | $5.49M |
| Total Operating Expenses | $13.31M | $12.68M | $10.90M | $14.63M | $14.25M |
| Operating Income | ($13.28M) | ($12.68M) | ($9.90M) | ($14.63M) | ($10.22M) |
| Operating Margin %(computed) | — | — | -990.03% | — | -253.02% |
| Interest Income | $1.30M | $1.67M | $1.83M | $0.81M | $0.14M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($11.99M) | ($11.04M) | ($8.57M) | ($14.07M) | ($10.13M) |
| Income Tax Expense | $0.01M | $0.01M | $0.00M | $0.00M | $0.00M |
| Net Income | ($12.00M) | ($11.05M) | ($8.57M) | ($14.07M) | ($10.13M) |
| Net Margin %(computed) | — | — | -857.15% | — | -251.00% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 |
| Wtd Avg Shares | 49.06M | 49.05M | 49.05M | 49.05M | 48.60M |
| EBITDA | ($11.97M) | ($12.65M) | ($9.88M) | ($14.61M) | ($10.19M) |
| EBITDA Margin %(computed) | — | — | -988.00% | — | -252.38% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more MediciNova, Inc. data
About MediciNova, Inc. (MNOV) Income Statement
MediciNova, Inc. (MNOV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MNOV reported revenue of $0.00B, gross profit of $0.00B (gross margin 7.58%), and net income of ($0.01B) — a net profit margin of -2928.78%.
Frequently asked questions
MNOV · 4 questionsMediciNova, Inc. (MNOV) reported revenue of $0.00B for 2025, up —% year-over-year.
MNOV revenueMNOV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09